| Aug 26 |
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Data Results with Completion of Clinical Study of Elevai Enfinity™ Topical Exosome Serum
|
| Aug 26 |
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
|
| Aug 19 |
Elevai Labs Second Quarter 2024 Earnings: US$0.077 loss per share (vs US$0.13 loss in 2Q 2023)
|
| Aug 19 |
Elevai Labs Inc. Subsidiary, Elevai Research Inc., Announces Preliminary Positive Research Data Highlighting the Potential of Proprietary Exosome Technology for Skin Health Applications
|
| Aug 15 |
Elevai Labs reports Q2 results
|
| Aug 14 |
Elevai Labs Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update
|
| Jul 30 |
Elevai Labs Inc. Subsidiary, Elevai Biosciences, Continues to Advance its Scientific Advisory Board with the Appointment of Orian Shirihai, MD, PhD
|
| Jul 17 |
Next Generation Skin & Scalp Rejuvenation Slideshow
|
| Jul 16 |
Top 4 Risk Off Stocks You'll Regret Missing In July
|
| Jun 28 |
Elevai Labs Inc. Subsidiary, Elevai Skincare, Announces The Elevai S-Series Hair and Scalp Care Product Line
|
